Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze EWTX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate EWTX investment potential.

What is EWTX stock price today?

Get real-time EWTX stock price, historical data, and price charts on Financhill. Track EWTX performance with our advanced analysis tools.

Is EWTX a good investment?

Evaluate EWTX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy EWTX stock?

To buy EWTX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of EWTX?

View detailed market capitalization data and company valuation metrics for EWTX on our comprehensive analysis page.

What is the P/E ratio of EWTX?

Use our fundamental analysis tools to view EWTX P/E ratio and compare valuation metrics with industry peers.

What are EWTX earnings?

View EWTX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Edgewise Therapeutics, Inc. Stock Predictions

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

EWTX
Edgewise Therapeutics, Inc.

Last Price:

$22.77

Seasonality Move:

18.92%

7 Day Trial

ALL ACCESS PASS

$ 7

14K Investors Got In Earlier. You Still Can.

Edgewise Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Edgewise Therapeutics, Inc. has on average historically risen by 60.4% based on the past 4 years of stock performance.
Edgewise Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Is Edgewise Therapeutics, Inc. Stock Undervalued?

The current Edgewise Therapeutics, Inc. [EWTX] share price is $23.94. The Score for EWTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
EWTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Edgewise Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Edgewise Therapeutics, Inc. has on average historically risen by 60.4% based on the past 4 years of stock performance.

Edgewise Therapeutics, Inc. Stock Rating

Buy

Edgewise Therapeutics, Inc. (EWTX) is a Buy

Is Edgewise Therapeutics, Inc. overpriced?

Edgewise Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Edgewise Therapeutics, Inc. Stock Price History

Is EWTX stock going to rise?

The current trend is moderately bearish and EWTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

edgewisetx.com

52-Week Data

52-Week High:

35.50

52-Week Low:

10.60

Prediction Charts

Market Cap:

2.5B

Price in USD:

23.94

Volume:

3.7M

Beta:

0.26

Technical Analysis

SMA50:

19.53

SMA100:

17.00

SMA200:

16.75

52-Wk Change:

-13.32%

Stock Predictions

Is Edgewise Therapeutics, Inc. stock public?

Yes, Edgewise Therapeutics, Inc. is a publicly traded company.
What is the Edgewise Therapeutics, Inc. stock quote today?

The Edgewise Therapeutics, Inc. stock price is 23.94 USD today.
How to buy Edgewise Therapeutics, Inc. stock online?

You can buy Edgewise Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-25	23.48	24.06	24.15	23.28
Nov-26	24.24	25.52	25.93	23.86
Nov-28	25.62	26.04	26.30	25.29
Dec-1	26.04	25.27	26.24	25.03
Dec-2	25.27	22.98	25.66	22.95
Dec-3	23.05	23.32	23.48	22.51
Dec-4	23.44	23.71	24.04	23.14
Dec-5	23.72	23.59	24.27	23.48
Dec-8	24.10	23.56	24.66	23.22
Dec-9	23.56	23.34	24.08	23.13
Dec-10	23.58	23.74	24.39	23.46
Dec-11	24.05	23.43	24.51	23.32
Dec-12	24.01	23.62	25.00	22.77
Dec-15	23.67	23.94	24.31	22.99

Edgewise Therapeutics, Inc. Earnings

Edgewise Therapeutics, Inc. Earnings Report: Per Share Edgewise Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Edgewise Therapeutics, Inc. Forecast Revenue Growth

Edgewise Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Edgewise Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.38 per share.

* Edgewise Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.